Hummingbird ICE Study

Starting soon

Conditions studied: ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF), Valve Disease, Heart, Atrial Septal Defect, Patent Foramen Ovale, Tricuspid Valve Disease

In brief

The goals of this observational study are to collect data and ultrasound images using the Philips VeriSight Pro intracardiac echocardiography (ICE) catheter to assess safety and effectiveness and to support development efforts of the VeriSight Pro imaging platform.

Key facts

Study ID

NCT07552272

Run by

Philips Clinical & Medical Affairs Global

People needed

1000

Starts

2026-07-01

Expected to finish

2031-07-01

Last updated by the study team

2026-05-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age
• Willing to provide written, dated and signed, informed consent
• Undergoing percutaneous cardiac intervention procedures in with VeriSight Pro is used

You may not qualify if…

• Contraindicated for ICE catheter placement or considerations that make placement of VeriSight not technically feasible
• Known contraindicated conditions include sepsis, major coagulation abnormalities, presence of any intracardiac thrombus, presence of class IV angina or heart failure, deep vein thrombosis, or significant peripheral vascular disease

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.